ARCHIVES

Harvard’s DePinho Becomes Finalist at MD Anderson

This article is from The Cancer Letter archive.

Vol. 37 No. 20 | May 20, 2011

Download PDF Visit The Full Archive

Related Articles

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

July 6, 1984

Cancer Mortality Increase Of 5.2% Now 28% Or Less

January 30, 1976

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

Abstracts Of “Most Newsworthy” Papers At AACR Meeting

May 27, 1977

BRAF Mutation Testing Classifies Indeterminate FNA Samples

March 29, 2013